Publications by authors named "Banu Kadıoglu Yılmaz"

Objectives: Tangier disease (TD) is a rare autosomal recessive condition characterized by high-density lipoprotein (HDL) deficiency; involving symptoms of polyneuropathy, hyperplastic orange-yellow tonsils, vision disorder, and sudden cardiac death. The major clinical symptoms of TD may not all be co-present. This study evaluates patients diagnosed with TD in childhood to improve the possibility of early diagnosis of asymptomatic cases by reporting our patients' clinical characteristics in order to minimize delayed diagnosis and emphasize the importance of TD, easily detected by HDL measurement.

View Article and Find Full Text PDF

This study aims to determine the allele and genotype frequency, evaluate genotype-phenotype correlation and contribute to the spectrum of pathogenic variants in the PAH gene. Ninety-three individuals diagnosed with PKU were included in the study. Next-generation sequencing was utilized for detecting variants in the PAH gene.

View Article and Find Full Text PDF

This study aims to evaluate the process of neonatal phenylketonuria (PKU) screening from birth to admission to the pediatric metabolism polyclinic, determining delays in the screening program and the factors influencing them. This study was conducted during 2021-2023. Blood collection dates, results, and probable parameters causing delays in the screening program were recorded.

View Article and Find Full Text PDF

Background: Cerebrotendinous xanthomatosis (CTX, OMIM #213700) is a rare but treatable lipid storage disease resulting from mutations in the CYP27A1 gene.

Purpose: The study aims to evaluate patients diagnosed with CTX and reveal new information, especially about the signs of CTX and patients' response to the treatment.

Methods: The study was conducted retrospectively in 12 definitively diagnosed CTX patients.

View Article and Find Full Text PDF

Objective: The purpose of this study is comparing the newborn hearing screening failure rate between phenylketonuria (PKU) infants and matched healthy control infants.

Patients And Methods: Between April 2021 and April 2023, data obtained from the national newborn hearing screening program were examined for patients who presented to the pediatric metabolism clinic of Konya City Hospital with a clinical and genetic diagnosis of PKU. A healthy control group, matched for age and gender, was established.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess cardiovascular risks in children with classical phenylketonuria (PKU) by comparing their glycemic index (GI), obesity, and echocardiographic measurements with a healthy control group.
  • Conducted between 2019 and 2020, the research involved 104 pediatric volunteers divided into two groups (PKU patients and healthy controls) with further subdivisions by weight status, analyzing various health metrics.
  • Results showed significant differences in cholesterol and glucose levels, with PKU patients having lower values but higher triglycerides. Additionally, left ventricular mass was notably greater in the PKU group, highlighting the need for monitoring phenylalanine levels and pulse wave velocity over obesity for cardiovascular health.
View Article and Find Full Text PDF

Bibliometric studies on inherited metabolic diseases (IMDs) do not exist in the literature. Therefore, our research aims to conduct a bibliometric study to determine the current status, trending topics, and missing points of publications on IMDs. Between 1968 and 2023, we conducted a literature search with the keyword "inherited metabolic disease" in the SCOPUS database.

View Article and Find Full Text PDF

Büyükkaragöz B, Bakkaloğlu SA, Tuncel AF, Kadıoğlu-Yılmaz B, Karcaaltıncaba D, Paşaoğlu H. Evaluation of growth in children and adolescents after renal transplantation. Turk J Pediatr 2019; 61: 217-227.

View Article and Find Full Text PDF